Latest filing published 22 Apr 2022 for Outlook Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
BioLexis Pte Ltd.: trading record in brief
All filings by BioLexis Pte Ltd. on record concern Outlook Therapeutics, Inc. In total, 10 filings cover trades dated from 7 November 2018 to 21 April 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 22 April 2022 with a transaction in Outlook Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to BioLexis Pte Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 27,982,529 sharesCommon StockSEC:0000947871-22-000475:0
1 of 1 declaration